Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001013762-25-004387
Filing Date
2025-03-28
Accepted
2025-03-28 21:47:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 9448
  Complete submission text file 0001013762-25-004387.txt   11189
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Subject) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-94408 | Film No.: 25788493
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 650 GEORGIA ST #3200 VANCOUVER A1 V6B4P7
Business Address
Braeden Lichti (Filed by) CIK: 0001982476 (see all company filings)

Type: SCHEDULE 13D